1
0
0
(1 - 10 von 13
)
Optimization of Chloronitrobenzamides (CNBs) as ...American Chemical Society
pubs.acs.org
von JY Hwang · · Zitiert von: 16 — European Journal of Medicinal Chemistry 2015, 97 , https://doi.org j.ejmech ; Heike Schönherr, Tim Cernak. › doi › abs
Ausgeprägte Methyleffekte in der Wirkstoff-Forschung und ...Wiley
onlinelibrary.wiley.com
von H Schönherr · · Zitiert von: 41 — Dr. Heike Schönherr,. Dr. Heike Schönherr. Department of Ophthalmology, Columbia University Medical Center, 635 W 165th St., New York, NY, ...
Fragment-based Differential Targeting of PPI Stabilizer ...Archive ouverte HAL
hal.science
von X Guillory · · Zitiert von: 29 — ... Joe Patel, Robert Goodnow,. Heike Schoenherr, Nathan Fuller, Qing Cao, Richard G. Doveston, Luc Brunsveld, Michelle R. Arkin,.
A Chemoenzymatic Approach to the Stereocontrolled ...Chemistry Europe
chemistry-europe.onlinelibrary.wiley.com
von H Schönherr · · Zitiert von: 7 — A Chemoenzymatic Approach to the Stereocontrolled Synthesis of the C1–C11 fragment of (+)-Peloruside A. Heike Schönherr,. Heike Schönherr. von H Schönherr · · Zitiert von: 7 — A Chemoenzymatic Approach to the Stereocontrolled Synthesis of the C1–C11 fragment of (+)-Peloruside A. Heike Schönherr,. Heike Schönherr.
An improved model for fragment-based lead generation at ...ScienceDirect.com
www.sciencedirect.com
von N Fuller · · Zitiert von: 77 — , Loredana Spadola 2 5 , Scott Cowen 1 , Joe Patel 1 , Heike Schönherr 1 , Qing Cao 1 , Andrew McKenzie 1 6 , Fredrik Edfeldt 3 , Al Rabow 4 , Robert Goodnow ... von N Fuller · · Zitiert von: 77 — , Loredana Spadola 2 5 , Scott Cowen 1 , Joe Patel 1 , Heike Schönherr 1 , Qing Cao 1 , Andrew McKenzie 1 6 , Fredrik Edfeldt 3 , Al Rabow 4 , Robert Goodnow ...
An improved model for fragment-based lead generation at ...National Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von N Fuller · · Zitiert von: 78 — Nathan Fuller , Loredana Spadola , Scott Cowen , Joe Patel , Heike Schönherr , Qing Cao , Andrew McKenzie , Fredrik Edfeldt , Al Rabow , Robert Goodnow ...
Discovery of lirafugratinib (RLY-4008), a highly selective ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von H Schönherr · · Zitiert von: 3 — Heike Schönherr , Pelin Ayaz , Alexander M Taylor , Jessica B Casaletto , B Barry Touré , Demetri T Moustakas , Brandi M ... von H Schönherr · · Zitiert von: 3 — Heike Schönherr , Pelin Ayaz , Alexander M Taylor , Jessica B Casaletto , B Barry Touré , Demetri T Moustakas , Brandi M ...
Discovery of lirafugratinib (RLY-4008), a highly selective ...PNAS
www.pnas.org
von H Schönherr · · Zitiert von: 3 — ... Heike Schönherr https://orcid.org , Pelin Ayaz https://orcid.org , Alexander M. Taylor, + von H Schönherr · · Zitiert von: 3 — ... Heike Schönherr https://orcid.org , Pelin Ayaz https://orcid.org , Alexander M. Taylor, +
Fragment-based Differential Targeting of PPI Stabilizer ...Eindhoven University of Technology research portal
research.tue.nl
von X Guillory · · Zitiert von: 37 — ... Heike Schoenherr, Nathan Fuller, Qing Cao, Richard G Doveston, Luc Brunsveld, Michelle R Arkin, M Paola Castaldi, Helen BoydIsabelle ... von X Guillory · · Zitiert von: 37 — ... Heike Schoenherr, Nathan Fuller, Qing Cao, Richard G Doveston, Luc Brunsveld, Michelle R Arkin, M Paola Castaldi, Helen BoydIsabelle ...
RLY-4008, the First Highly Selective FGFR2 Inhibitor with ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von V Subbiah · · Zitiert von: 21 — Patrick J O'Hearn , Demetri T Moustakas , Heike Schönherr , Nastaran Gerami-Moayed , Alexander M Taylor , Brandi M Hudson ... von V Subbiah · · Zitiert von: 21 — Patrick J O'Hearn , Demetri T Moustakas , Heike Schönherr , Nastaran Gerami-Moayed , Alexander M Taylor , Brandi M Hudson ...
Alle Infos zum Namen "Heike Schönherr"
Verwandte Suchanfragen zu Heike Schönherr
Nathan Fuller Karl Liebknecht Pelin Ayaz | Sven Wallrath Hardi Schaarschmidt Dana Steuernagel |
Person "Schönherr" (4) Vorname "Heike" (42954) Name "Schönherr" (829) |
sortiert nach Relevanz / Datum